Family support boosts opioid treatment success

NCT ID NCT04239235

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding a support person—like a family member or friend—to standard buprenorphine treatment helps people with opioid addiction stay in treatment longer. 439 patients and their support persons took part. The support persons learned CRAFT, a counseling program that teaches them how to encourage their loved one's recovery. The main goal was to see if patients stayed on buprenorphine for at least 6 or 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
buprenorphine/naloxone
What this could lead to
If successful, this approach could improve treatment retention and reduce opioid use for people with opioid addiction.
What could go wrong
This is a completed study, but results may not apply to all settings. The intervention relies on having a willing support person, which not everyone has.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID ADDICTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Behavioral Health Services

    Gardena, California, 90249, United States

  • Contra Costa Health Services

    Concord, California, 94553, United States

  • Family Health Centers of San Diego

    San Diego, California, 92110, United States

  • Lifelong Medical Care

    Berkeley, California, 94703, United States

  • Open Door Community Health Centers

    Arcata, California, 95521, United States

  • Venice Family Clinic

    Venice, California, 90291, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.